SBX.DE
Price:
$1.68
Market Cap:
$9.49M
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-01-07
Stock Exchange
XETRA
Ticker
SBX.DE
According to SynBiotic SE’s latest financial reports and current stock price. The company's current Enterprise Value is 13.08M. This represents a change of -56.55% compared to the average of 30.10M of the last 4 quarters.
The mean historical Enterprise Value of SynBiotic SE over the last ten years is 37.09M. The current 13.08M Enterprise Value has changed 3.43% with respect to the historical average. Over the past ten years (40 quarters), SBX.DE's Enterprise Value was at its highest in in the June 2022 quarter at 66.71M. The Enterprise Value was at its lowest in in the December 2021 quarter at -2264039.00.
Average
37.09M
Median
30.92M
Minimum
5.55M
Maximum
90.88M
Discovering the peaks and valleys of SynBiotic SE Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 411.83%
Maximum Annual Enterprise Value = 90.88M
Minimum Annual Increase = -83.39%
Minimum Annual Enterprise Value = 5.55M
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | 17.59M | -62.34% |
| 2022 | 46.70M | -48.61% |
| 2021 | 90.88M | 219.81% |
| 2020 | 28.42M | 411.83% |
| 2019 | 5.55M | -83.39% |
The current Enterprise Value of SynBiotic SE (SBX.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
51.73M
5-year avg
37.83M
10-year avg
37.09M
SynBiotic SE’s Enterprise Value is less than Maternus-Kliniken AG (184.77M), less than aap Implantate AG (18.70M), greater than NanoRepro AG (10.39M), greater than Geratherm Medical AG (11.97M), greater than Oakridge International Limited (2.00M), greater than AS Latvijas Juras medicinas centrs (5.75M), greater than elexxion AG (5.38M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 184.77M | $22.23M | |
| 18.70M | $19.05M | |
| 10.39M | $19.49M | |
| 11.97M | $16.99M | |
| 2.00M | $809.94K | |
| 5.75M | $6.72M | |
| 5.38M | $1.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SynBiotic SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SynBiotic SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is SynBiotic SE's Enterprise Value?
What is the highest Enterprise Value for SynBiotic SE (SBX.DE)?
What is the 3-year average Enterprise Value for SynBiotic SE (SBX.DE)?
What is the 5-year average Enterprise Value for SynBiotic SE (SBX.DE)?
How does the current Enterprise Value for SynBiotic SE (SBX.DE) compare to its historical average?